Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CFMS |
---|---|---|
09:32 ET | 1540 | 1.68 |
09:34 ET | 680 | 1.6615 |
09:45 ET | 500 | 1.65 |
09:48 ET | 500 | 1.68 |
09:52 ET | 573 | 1.69 |
09:54 ET | 100 | 1.6908 |
10:01 ET | 24899 | 1.63 |
10:03 ET | 2974 | 1.63 |
10:10 ET | 4370 | 1.6347 |
10:21 ET | 3800 | 1.6 |
10:24 ET | 6090 | 1.5801 |
10:26 ET | 9879 | 1.54 |
10:32 ET | 700 | 1.56 |
10:48 ET | 100 | 1.5884 |
10:51 ET | 587 | 1.5685 |
11:02 ET | 120 | 1.56 |
11:04 ET | 2723 | 1.5758 |
11:33 ET | 102 | 1.6037 |
11:36 ET | 400 | 1.615 |
11:40 ET | 100 | 1.58 |
11:44 ET | 100 | 1.58 |
11:45 ET | 200 | 1.6246 |
12:20 ET | 300 | 1.6 |
12:32 ET | 480 | 1.58 |
12:34 ET | 200 | 1.58 |
12:36 ET | 1000 | 1.6 |
12:39 ET | 380 | 1.6008 |
12:48 ET | 118 | 1.6017 |
01:15 ET | 187 | 1.6188 |
01:33 ET | 200 | 1.62 |
01:44 ET | 200 | 1.61 |
01:51 ET | 200 | 1.6199 |
02:40 ET | 100 | 1.64 |
03:09 ET | 200 | 1.6328 |
03:16 ET | 584 | 1.62 |
03:23 ET | 600 | 1.629 |
03:32 ET | 732 | 1.62 |
03:54 ET | 300 | 1.61 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Conformis Inc | 12.1M | -0.2x | --- |
Biocept Inc | 5.8M | -0.3x | --- |
Trinity Biotech PLC | 19.6M | -0.5x | --- |
Sientra Inc | 15.6M | -0.1x | --- |
Aziyo Biologics Inc | 24.4M | -0.6x | --- |
Surgalign Holdings Inc | 10.8M | -0.1x | --- |
Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.1M |
---|---|
Revenue (TTM) | $62.1M |
Shares Outstanding | 7.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.09 |
EPS | $-7.00 |
Book Value | $7.22 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -74.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.